AnalysisNews

AHR today

$59.23-$0.16 (-0.27%)close Nov 11, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bullish

1 hourBearish

15 minBearish

5 minDescending Triangle

Daily trend turns up above $57.46

Key levels

Support$58.70

Support$56.78

Latest news & SEC filings

AnalystUBS keeps Buy rating on American Healthcare REIT, lifts target to $71

AnalystUBS lifts its valuation level for American Healthcare REIT to $71

NewsAmarc Resources and Boliden start exploration work at DUKE property

SEC FilingAmerican Healthcare REIT, Inc. filed an insider trading report (Form 4)

All AHR news →

About American Healthcare REIT

This real estate investment trust owns and runs clinical healthcare properties, handling its own management rather than hiring an outside firm. Its portfolio covers housing for older adults, nursing care centers, medical office buildings, and combined campuses offering multiple levels of care. The company operates across the United States, the United Kingdom, and the Isle of Man, leasing space to tenants and using a RIDEA structure through taxable REIT subsidiaries for certain care operations.

Based on the company's 10-K filed Feb 27, 2026.

NYSE · Real Estate

American Healthcare REIT, Inc. (AHR)

$59.23-0.16 (-0.27%)
WATCHLISTGrade: B+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
51.3753.3855.3857.3959.23Oct 9Oct 19Oct 27Nov 4
High59.55
Low59.03
Open59.17
Volume2.48M
Avg Vol3.11M
VWAP59.24
30d High59.39
30d Low49.37
30d Chg+16.85%

What Is the Price Target for AHR?

SEPT Low Target

$60.00

SEPT Mid Target

$65.50

SEPT High Target

$71.00

Analyst Consensus

$65.50

Current: $59.23Upside: +10.6%Confidence: 85%Method: Analyst Consensus

Is AHR a Buy or Sell Right Now?

66
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Nov 6▲ UpDilutionEarnings2 articles
American Healthcare REIT shares closed at $57.91, up 1.78% on volume of 5,918,722, trading between a low of $56.26 and a high of $58.06. The company announced a new $1.75 billion at-the-market equity program, replacing its prior sales agreement, a move that carries dilution risk for existing shareholders. It also held its Q3 2026 earnings call covering quarterly results. Despite the potential dilution overhang from the new ATM program, the stock finished higher on the session.
Critical news
Nov 5HIGHEarnings: growth/beat
Nov 5HIGHEarnings: growth/beat

Thesis

  • •Revenue growing 9.2% YoY with STRONG trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AHR.

Start Free Trial →

Is AHR Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$52.77

28

Moat Score

NONE

5/9

Piotroski Score

3.1

Altman Z-Score

What Is Smart Money Doing with AHR?

Insider Signal

SELLING

0 buys / 4 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
ESTES SCOTT AdirectorSale2,500$148KNov 10, 2026
Foster Mark E.officerSale1,500$78KSep 25, 2026
Foster Mark E.officerSale2,000$111KSep 1, 2026
Prosky DannydirectorSale59,945$3.4MJul 21, 2026
Prosky DannydirectorSale16,663$944KJul 21, 2026
Prosky DannydirectorSale11,283$639KJul 21, 2026
Prosky DannydirectorBuy2,594-Jul 21, 2026
PEAY BRIANofficerSale25,000$1.3MJun 26, 2026
Streiff Mathieu B.directorBuy2,594-Jun 24, 2026
ESTES SCOTT AdirectorBuy2,594-Jun 24, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

AHR Growth Story

Revenue YoY

9.2%

3yr Revenue CAGR

17.0%

EPS Growth YoY

244.83%

FCF Growth YoY

N/A%

Revenue Trend

STRONG

Dark Pool Trades for AHR

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for AHR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:57:11$59.23325,453$$19.3MBUY
21:00:20$59.2311,600$$687KBUY
21:00:20$59.233,473$$206KBUY
21:00:20$59.231,976$$117KBUY
21:00:20$59.234,800$$284KBUY

5 dark pool trades shown · $$20.6M preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for American Healthcare REIT, Inc. (AHR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

AHR — frequently asked questions

What is AHR stock price today?

American Healthcare REIT, Inc. (AHR) is at $59.23, down 0.27% (-$0.16) at the Nov 11, 2026 close.

Why is AHR stock moving today?

Latest AHR news — Nov 11, 2026: UBS keeps Buy rating on American Healthcare REIT, lifts target to $71 · Nov 11, 2026: UBS lifts its valuation level for American Healthcare REIT to $71

Why did AHR stock move on Nov 6, 2026?

American Healthcare REIT shares closed at $57.91, up 1.78% on volume of 5,918,722, trading between a low of $56.26 and a high of $58.06. The company announced a new $1.75 billion at-the-market equity program, replacing its prior sales agreement, a move that carries dilution risk for existing shareholders.

What is the AHR price target?

The average analyst price target for AHR is $65.50, ranging from $60 to $71, based on 10 analysts. Latest: UBS maintains on Nov 11, 2026.

What do analysts rate AHR?

Analyst ratings for AHR: 1 Buy, 17 Hold, 0 Sell — consensus Hold.

Did AHR beat earnings?

AHR last reported on Nov 5, 2026: EPS $0.14 vs $0.15 expected — a miss of 9.0%.

What is AHR's P/E ratio?

AHR trades at a P/E of 118.8 vs a Real Estate average of 25.1.

Does AHR pay a dividend?

Yes. AHR's dividend yield is 2.09%.

What are AHR support and resistance levels?

Support: $58.70, $56.78, $54.71.

What are insiders doing with AHR?

Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.

What is the latest news on AHR?

Nov 11, 2026: UBS keeps Buy rating on American Healthcare REIT, lifts target to $71 · Nov 11, 2026: UBS lifts its valuation level for American Healthcare REIT to $71 · Nov 11, 2026: Amarc Resources and Boliden start exploration work at DUKE property